Alzheimer’s drug trial success
Following the success of early research results of Anavex 2-73, a drug which aims to address the symptoms of dementia, Alfred Health is looking to continue a larger trial next year.
Visitor information – Everything you need to know about visiting our sites.
Following the success of early research results of Anavex 2-73, a drug which aims to address the symptoms of dementia, Alfred Health is looking to continue a larger trial next year.
A Victorian patient with Alzheimer's disease has become the first in the world to be given a new drug that experts hope will further treatment for the most common form of dementia.